CoChat

Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression

Bartels, Claudia, Wagner, Michael, Wolfsgruber, Steffen, Ehrenreich, Hannelore, Schneider, Anja, for the Alzheimer’s Disease Neuroimaging Initiative · 2018 · American Journal of Psychiatry

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Depression is associated with an increased risk of Alzheimer's disease. Research has shown that the selective serotonin reuptake inhibitor (SSRI) citalopram decreases amyloid-β generation and plaque load. The authors evaluated the impact of SSRI treatment on CSF biomarkers and progression from mild cognitive impairment (MCI) to Alzheimer's dementia. METHOD: Data sets from 755 currently nondepressed participants from the longitudinal Alzheimer's Disease Neuroimaging Initiative were evaluated by Kaplan-Meier analysis and analyses of variance and covariance with ApoE4 status and age as covariates. RESULTS: In MCI patients with a history of depression, long-term SSRI treatment (>4 years) was significantly associated with a delayed progression to Alzheimer's dementia by approximately 3 years, compared with short-term SSRI treatment, treatment with other antidepressants, or no treatment and compared with MCI patients without a history of depression. No differences in CSF biomarker levels were observed between treatment groups. CONCLUSIONS: Long-term SSRI treatment may delay progression from MCI to Alzheimer's dementia.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2017.17040404

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Research works printed but not linked: 1

  1. Bubu OM, Sleep

Cited by

See all 210

Metadata

Authors
Bartels, C., Wagner, M., Wolfsgruber, S., Ehrenreich, H., Schneider, A., & Initiative, F. T. A. D. N.
Affiliations
University of Bonn (DE)
Venue
American Journal of Psychiatry
Published
2018-03-01
Volume
175
Issue
3
Pages
232-241
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2768441608
Cited by
202
References
50
Citations by year
2026: 12 · 2025: 25 · 2024: 26 · 2023: 26 · 2022: 29 · 2021: 34 · 2020: 15 · 2019: 19 · 2018: 15
FWCI
11.01
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • DZNE Pub (publishedVersion)
  • Max Planck Digital Library (submittedVersion)
  • GRO (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • National Institutes of Health (5u01ag024904-10)
  • National Institute on Aging (U01-AG-024904)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
selective serotonin reuptake inhibitors, citalopram, mild cognitive impairment, Alzheimer's disease, conversion to dementia, history of depression, cerebrospinal fluid biomarkers, amyloid-beta, APOE ε4, antidepressant treatment duration, Alzheimer's Disease Neuroimaging Initiative
MeSH terms
Aged, Alzheimer Disease, Depression, Humans, Risk Factors, Citalopram, Selective Serotonin Reuptake Inhibitors, Kaplan-Meier Estimate, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression. https://app.cochat.ai/papers/10.1176/appi.ajp.2017.17040404
The paper
Bartels, C., Wagner, M., Wolfsgruber, S., Ehrenreich, H., Schneider, A., & Initiative, F. T. A. D. N. (2018). Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2017.17040404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.